Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02558348 |
| Title | Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) |
| Acronym | AL3818 |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Advenchen Laboratories, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
| Huntsman Cancer Institute, University of Utah | Salt Lake City | Utah | 84112 | United States | Details |